Literature DB >> 6607948

Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.

K Dorshkind, G M Keller, R A Phillips, R G Miller, G C Bosma, M O'Toole, M J Bosma.   

Abstract

Cells from mice with severe combined immunodeficiency disease (SCID) were tested in assays that measure myeloid and lymphoid function. Results showed that C.B-17 scid and their normal counterparts (C.B-17) have similar levels of spleen colony-forming units. The frequency of in vitro myeloid colony-forming units in C.B-17 scid spleen is elevated, but the absolute number of colony-forming units in C.B-17 scid and C.B-17 spleen is similar. The absolute number of bone marrow colony-forming units in C.B-17 scid and C.B-17 mice is comparable. Cells from C.B-17 scid spleen are consistently negative in all tests of B and T cell function. C.B-17 scid splenocytes fail to proliferate in response to T and B cell mitogens or to allogeneic lymphocytes in a one-way MLR; C.B-17 scid cells do serve as stimulators in MLR. B lymphocyte colony-forming units are absent, as are cytotoxic lymphocyte precursors and cells that can generate T cell colonies with cytotoxic progenitors. The microenvironment of the C.B-17 scid mouse is conducive to lymphocyte differentiation, because functional B and T cells are easily detectable in mice reconstituted with normal bone marrow cells. The results of this study indicate that scid specifically impairs the differentiation of stem cells into mature lymphocytes; myeloid cell differentiation is not affected.

Entities:  

Mesh:

Year:  1984        PMID: 6607948

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Experimental infection of severe combined immunodeficient beige mice with Mycobacterium paratuberculosis of bovine origin.

Authors:  G K Mutwiri; D G Butler; S Rosendal; J Yager
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 2.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Wild-type V(D)J recombination in scid pre-B cells.

Authors:  E A Hendrickson; M S Schlissel; D T Weaver
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.

Authors:  Jifeng Zhang; Brice E Barefoot; Wenjian Mo; Divino Deoliveira; Jessica Son; Xiuyu Cui; Elizabeth Ramsburg; Benny J Chen
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

5.  Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  R Narayanan; W A Joyce; R A Greenfield
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 6.  Current status review: the severe combined immunodeficient (SCID) mouse: xenogeneic-SCID chimeras in the investigation of human autoimmune disease.

Authors:  P C Taylor
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

7.  Reconstitution of SCID mice with haemopoietic precursors: a detailed analysis of gamma delta T-cell reconstitution.

Authors:  K A Kelly; R O'Brien; W Born
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

8.  T cell receptor expression is not required for the localization and differentiation of intraepithelial lymphocytes.

Authors:  K Croitoru; R H Stead; J Bienenstock; L D Shultz; P B Ernst
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

9.  The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.

Authors:  Aminul Islam; Michelle Lockhart; John Stenos; Stephen Graves
Journal:  Am J Trop Med Hyg       Date:  2013-08-19       Impact factor: 2.345

10.  Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.

Authors:  A G Murray; J S Schechner; D E Epperson; P Sultan; J M McNiff; C C Hughes; M I Lorber; P W Askenase; J S Pober
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.